(Q31113892)

28 June 2017

1 reference

title

Differential diagnosis of multiple sclerosis (English)

1 reference

28 June 2017

0 references

Halim Fadil

1

1 reference

PubMed ID

17531852

28 June 2017

Roger E Kelley

series ordinal

2

1 reference

PubMed ID

17531852

28 June 2017

Eduardo Gonzalez-Toledo

series ordinal

3

1 reference

28 June 2017

1 January 2007

1 reference

International Review of Neurobiology

28 June 2017

1 reference

28 June 2017

79

1 reference

28 June 2017

393-422

1 reference

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Idiopathic granulomatous angiitis of the CNS manifesting as diffuse white matter disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Vasculitis in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

The phenotypic spectrum of CADASIL: clinical findings in 102 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Antinuclear antibodies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Neuroimaging findings in neurosyphilis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Primary CNS lymphoma in immunocompetent patients from 1989 to 2001: a retrospective analysis of 164 cases uniformly diagnosed by stereotactic biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Idiopathic granulomatous angiitis of the CNS manifesting as diffuse white matter disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Mitochondrial encephalomyopathy--two years follow-up by MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

The coexistence of systemic lupus erythematosus and multiple sclerosis in a mother and daughter

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Magnetic resonance imaging of the brain in patients with migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Treatment of Marburg variant multiple sclerosis with mitoxantrone

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Primary Sjögren's syndrome initially manifested by optic neuritis: MRI findings

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Neurological complications in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Wegener granulomatosis: MR imaging findings in brain and meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

1 reference

7 January 2021

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Polyarteritis nodosa with central nervous system involvement mimicking meningoencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Inflammatory transverse myelitis: evolving concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Early lacunar strokes complicating polyarteritis nodosa: thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system--value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Central nervous system involvement in Wegener granulomatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Neurosarcoidosis: a personal perspective based on the study of 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behçet's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Vasculitis of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

High-signal periventricular lesions in patients with sarcoidosis: neurosarcoidosis or multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Sarcoidosis and its neurological manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

MRI findings in Susac's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

MRI in neuro-Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Relapsing cervical cord lesions on MRI in patients with HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Intracranial Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

Leber's hereditary optic neuropathy: a multifactorial disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2979018-9

7 January 2021

10.1016/S0074-7742(07)79018-9

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

17531852